Investors Flock to Biotech March 03, 2014 | Press Release
Biotech IPOs Off to a Strong Start in 2014 February 03, 2014 | Press Release
Idea to IPO - Transitions in Healthcare 2014 January 29, 2014 | Press ReleaseSee all News
Anton GuethSenior Advisor
Mr. Gueth began his management career in business and alliance development over 20 years ago at Eli Lilly and Company. His global experience spans the U.S., Europe, the Middle East and Africa. Before joining Burrill Securities, Mr. Gueth was an independent consultant for pharmaceutical and biotechnology clients in the areas of licensing, early-stage financing and alliance management. His clients included Baxter, Amgen, Boehringer Ingelheim, Schering-Plough and Schering AG, among others. While at Lilly, Mr. Gueth held multiple positions of increasing responsibility, concluding as Director of Alliance Management. In this role he led Lilly’s efforts to become “the pharmaceutical partner of choice”. Mr. Gueth is a member of the board of directors of Antares Pharma. He is also on the board of the California chapter of the American Liver Foundation. An author and lecturer, Mr. Gueth has contributed to industry reports from In Vivo and Ernst and Young as well as business texts on strategic alliances. Mr. Gueth received his master’s degree in public affairs from Indiana University and an M.S. in agricultural economics from Justus Liebig University in Germany.